ArticleCancer reports (Hoboken, N.J.)2021

Characteristics of central nervous system progression in non-small cell lung cancer treated with crizotinib or alectinib.

Hiroaki Sakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.